These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

174 related items for PubMed ID: 486317

  • 1. Fc receptor-bearing and phagocytic cells in syngeneic tumours of C. parvum- and carrageenan-treated mice.
    Thomson AW, Cruickshank N, Fowler EF.
    Br J Cancer; 1979 May; 39(5):598-602. PubMed ID: 486317
    [No Abstract] [Full Text] [Related]

  • 2. Corynebacterium parvum and cyclophosphamide as combination treatment for a murine mammary adenocarcinoma.
    Purnell DM, Bartlett GL, Kreider JW, Biro TG.
    Cancer Res; 1977 Apr; 37(4):1137-40. PubMed ID: 844041
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Antitumor activity of killed Corynebacterium parvum suspensions in a murine mammary adenocarcinoma CaD2) system.
    Purnell DM, Otterstrom JR, Bartlett GL, Kreider JW.
    J Natl Cancer Inst; 1976 Jun; 56(6):1171-5. PubMed ID: 994219
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Rejection of mammary adenocarcinoma cell tumors in DBA/2 mice immunocompromised by thymectomy and treatment with antithymocyte serum.
    Likhite VV.
    J Immunol; 1975 Jun; 114(6):1736-42. PubMed ID: 1092759
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Further observations on the inhibition of tumor growth by Corynebacterium parvum with cyclophosphamide. IX. Macrophage content of tumors in mice.
    Gebhardt MC, Fisher B.
    J Natl Cancer Inst; 1979 Apr; 62(4):1035-41. PubMed ID: 285276
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. C. parvum treatment of transplanted rat tumours of spontaneous origin.
    Willmott N, Pimm MV, Baldwin RW.
    Int J Cancer; 1979 Sep 15; 24(3):323-8. PubMed ID: 385514
    [Abstract] [Full Text] [Related]

  • 16. Radiation therapy and Corynebacterium parvum in the treatment of murine tumors.
    Suit HD, Sedlacek RS, Silobrcic V, Linggood RM.
    Cancer; 1976 Jun 15; 37(6):2573-9. PubMed ID: 949676
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Immunotherapy of an established rat mammary adenocarcinoma (13762A) with intratumor injection of Corynebacterium parvum.
    Kreider JW, Bartlett GL, Purnell DM, Webb S.
    Cancer Res; 1978 Mar 15; 38(3):689-92. PubMed ID: 626972
    [Abstract] [Full Text] [Related]

  • 19. Rejection of tumors and metastases in Fischer 344 rats following intratumor administration of killed Corynebacterium parvum.
    Likhite VV.
    Int J Cancer; 1974 Nov 15; 14(5):684-90. PubMed ID: 4459281
    [No Abstract] [Full Text] [Related]

  • 20. Influence of immunotherapeutic agents on the progression of spontaneously arising, metastasizing rat mammary adenocarcinomas of varying immunogenicities.
    Greager JA, Baldwin RW.
    Cancer Res; 1978 Jan 15; 38(1):69-73. PubMed ID: 618584
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.